Seshu Tyagarajan
Chief Technical and Development Officer @ Candel Therapeutics
About Seshu Tyagarajan
Seshu Tyagarajan serves as the Chief Technical and Development Officer and holds a Ph.D. along with a Regulatory Affairs Certification (RAC).
Known information
Seshu Tyagarajan is recognized for his role as the Chief Technical and Development Officer, where he oversees technical strategies and development processes. He has earned a Ph.D., which signifies his deep expertise in his field. Additionally, Tyagarajan is certified by the Regulatory Affairs Certification (RAC), further establishing his qualifications and ability to comply with industry regulations.
About Candel Therapeutics
Candel Therapeutics is a biotechnology company focused on developing viral immunotherapies for cancer, utilizing platforms like CAN-2409 and CAN-3110 to induce individualized immune responses against tumors.